QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION
K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M
2015
CMO
LEADERSHIP
AWARDS
WINNERS
Company
Profiles
LIFESCIENCELEADER.COM
THE CMO LEADERSHIP AWARDS 2015
67
DRUG TYPE:
Pharmaceuticals
DRUG TYPE:
Pharmaceuticals
DRUG TYPE:
Pharmaceuticals
DRUG LIFE CYCLE STAGES:
Research & Development: Clinical (Phase 1,
Phase 2, Phase 3)
Drug Substance Production: Primary Process
Development, Drug Substance Production
DRUG LIFE CYCLE STAGES:
Research & Development: Clinical (Phase 1,
Phase 2, Phase 3)
Drug Substance Production: Primary Process
Development, Drug Substance Production
Formulated Drug Production: Dosage Form
Development
DRUG LIFE CYCLE STAGES:
Research & Development: Preclinical, Clinical
(Phase 1, Phase 2, Phase 3)
Drug Substance Production: Primary Process
Development, Drug Substance Production
Formulated Drug Production: Dosage Form
Development, Dosage Form Production
"Helsinn is honored to receive this award covering
eight important client-partnering categories. We
believe this is a reflection of our continued efforts
in quality management and our ability to deliver
high quality products and services together with
our partners. This award represents a crowning
achievement for Helsinn Manufacturing and our
30-year history in pharmaceutical bulk drug
manufacturing."
"We have a quality culture that puts patient safety
first. This shapes our behaviors and motivates
us to improve and innovate. Our values read:
We are Principled Think Differently and Deliver.
Everything we do is about aligning ourselves with
our customers' goals, and we passionately turn
any challenge into a solution by working as a
team. These awards reward a great team effort.
Hovione people are amazing, and we're In It For
Life! "
"IDT helps companies fast-track products from
early API synthesis and dosage form development
& manufacture through to clinical trials. By
accessing the Australian R&D; Tax Incentive and
Clinical Trial Notification programs, our customers
can speed their product into clinical trials faster
and access up to a 43.5% cash rebate on their
R&D; spend. We help our customers to reach their
milestones quicker and to achieve more with their
development funding."
SERVICES & CAPABILITIES: cytotoxic & high
potency compounds, dry powder inhalers
devices, generics, hot melt extrusion, inhalation
formulation, particle engineering, powders (non-
sterile), spray d rying
SERVICES & CAPABILITIES: aseptic fill/finish,
capsules, controlled substances, cytotoxic &
high potency compounds, generics, injectables,
liquids, lyophilized products, non-sterile, solid
dose, solutions & suspensions, sterile, sustained
release, dedicated beta-lactam antibiotic API R&D;
and commercial manufacturing facility
WALDO MOSSI
general manager
GUY VILLAX
CEO
PAUL MACLEMAN
managing director
CATEGORIES WON CATEGORIES WON CATEGORIES WON
IDT Australia Ltd
Boronia, Victoria, Australia
www.idtaus.com.au
+61398018888
Mark Rowlands
mrowlands@idtaus.com.au
Key locations: Adelaide, Australia;
Melbourne, Australia
Hovione
Loures, Portugal
www.hovione.com
+351 21 9829362
Antonio Dinis
adinis@hovione.com
Key locations: Cork, Ireland; Loures, Portugal;
New Jersey, U.S.A.; Taipa, Macau
Helsinn Advanced Synthesis SA
Biasca, Switzerland
www.helsinn.com
+41 91 873 94 00
Sandra Moro
Sandra.Moro@Helsinn.com
Key locations: Biasca, Switzerland